TYK Medicines, Inc. (浙江同源康醫藥股份有限公司) has issued a notice and proxy form for its first extraordinary general meeting (EGM) of 2026, scheduled for 2:00 p.m. on Wednesday, 15 July 2026. The session will be held on the 8th Floor, Building T2, China Eastern Binjiang Center, No. 277 Longlan Road, Xuhui District, Shanghai.
The sole item on the agenda is a special resolution seeking a general mandate to issue shares. Shareholders will vote “For,” “Against” or “Abstain,” with abstentions recorded as votes carrying voting rights when the poll is counted.
H-share investors may appoint the chairman or another proxy to attend and vote. Completed proxy forms, together with any relevant authorisation documents, must reach the company’s Hong Kong H-share registrar—Computershare Hong Kong Investor Services Limited, 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai—no later than 24 hours before the meeting or any adjournment. Attendance in person remains an option, nullifying any previously submitted proxy.
Proxies are not required to be shareholders, but must attend in person and present identification. In the case of joint holders, only the first-named shareholder on the register is entitled to vote if multiple holders are present.
The full text of the resolution and related materials are available on the websites of the Hong Kong Stock Exchange (www.hkexnews.hk) and TYK Medicines (www.tykmedicines.com).
Comments